Claim this
Startup
Write to the
Cambridge Epigenetix

About Cambridge Epigenetix

Our starting point is TrueMethylTM oxidative bisulfite sequencing (oxBS-Seq), a novel technology that pioneers quantitative, single-base resolution sequencing of the modified bases hydroxymethyl cytos...

Cambridge Epigenetix describes itself with 5 words or categories

Health CareClinical TrialsHospitalsBiotechnologyHealth Diagnostics

Video

Presentation

Case Study

Competitive Landscape

Capitalization

Cambridge Epigenetix appears to have raised $5,500,000.

  • #DATA_YEAR# : $
    #NAME#
    from #DATA_FROM#